Work

A phase 1B/2 trial of avelumab and pepinemab as second line for metastatic pancreatic adenocarcinoma

Year: 2023

Type: article

Study design: Clinical Trial

Source: HPB

DOI: 10.1016/j.hpb.2023.05.303

Authors: L.I. Ruffolo, K.M. Jackson, N.A. Ullman, P.R. Burchard, M. Georger, R. Jewell, B.A. Belt, R.C. Fields, D. Mulkerin, E.E. Evans, T.L. Fisher, M. Zauderer, J. Yeh, D.C. Linehan

Institution: University of Rochester

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4381376795

FWCI:

Cites:

Cited by:

Related to: 10